Researcher
Marc De Maeyer
- Disciplines:Analytical biochemistry
Affiliations
- Biochemistry, Molecular and Structural Biology (Division)
Member
From1 Oct 2004 → Today
Projects
1 - 10 of 13
- Unravelling the hidden potential of two ORFans from Pseudomonas virus LUZ7From27 Aug 2015 → 22 Oct 2019Funding: BOF - Doctoral projects
- Molecular elucidation of three antibacterial proteins from Pseudomonas phage LUZ19 for biotechnological applicationsFrom1 Oct 2014 → 11 Dec 2019Funding: Own budget, for example: patrimony, inscription fees, gifts
- Rational design of small molecule modulators targeting the transcriptional function of the Salmonella Typhimurium response regulator PhoPFrom1 Oct 2013 → 8 Dec 2017Funding: Own budget, for example: patrimony, inscription fees, gifts
- Network-based approaches for the indification and mode of action determination of anti-bacterial agents .From1 Jan 2013 → 31 Dec 2016Funding: SBO (Strategic basic research)
- Computer-Aided Development of Biofilm Inhibitors for Slow Release from Metal Organic Frameworks.From1 Oct 2012 → 30 Sep 2016Funding: BOF - Concerted Research Project from 1994
- Computational study of protein-ligand interactions: Case study of SERCA and biofilm involved proteinsFrom1 Oct 2011 → 23 Mar 2017Funding: BOF - Doctoral projects
- Exploiting the BH4 domain of Bcl-2 as a novel target for the development of peptidomimetics that promote pro-apoptotic Ca2+ signaling.From1 Jan 2011 → 31 Dec 2014Funding: FWO research project (including WEAVE projects)
- Development of a structural database for improved rational kinase drug design.From1 Nov 2010 → 31 Oct 2011Funding: BOF - Other initiatives
- Unravelling the regulatory roles of defective invertases in plantsFrom1 Oct 2010 → 1 Oct 2014Funding: BOF - Doctoral projects
- A multi-disciplinary approach to exploit pro-apoptotic Ca2+ signaling as a novel anti-cancer strategy.From1 Oct 2010 → 30 Sep 2015Funding: BOF - Concerted Research Project from 1994
Publications
21 - 30 of 68
- Computational study of HIV gp41 FP and Rev as novel antiretroviral targets(2013)
Authors: Tom Venken, Marc De Maeyer, Arnout Voet
- Identification of small peptides inhibiting the integrase-LEDGF/p75 interaction through targeting the cellular co-factor(2013)
Authors: Frauke Christ, Arnout Voet, Eveline Lescrinier, Marc De Maeyer, Zeger Debyser, Erik Van der Eycken
Pages: 651 - 658 - Tuning the Size and Properties of ClyA Nanopores Assisted by Directed Evolution(2013)
Authors: Misha Soskine, Annemie Biesemans, Marc De Maeyer, Giovanni Maglia
Pages: 13456 - 63 - Understanding the role of defective invertases in plants: tobacco Nin88 fails to degrade sucrose(2013)
Authors: Marc De Maeyer, Wim Van den Ende
Pages: 1670 - 1681 - Mapping the binding interface between an HIV-1 inhibiting intrabody and the viral protein rev(2013)
Authors: Thomas Vercruysse, Eline Boons, Tom Venken, Els Vanstreels, Arnout Voet, Marc De Maeyer, Dirk Daelemans
- Rapid Conformational Fluctuations of Disordered HIV-1 Fusion Peptide in Solution(2013)
Authors: Tom Venken, Arnout Voet, Marc De Maeyer
Pages: 2870 - 2874 - An integrated fragment based screening approach for the discovery of small molecule modulators of the VWF-GPIbα interaction(2012)
Authors: Arnout Voet, Katleen Broos, Brecht Egle, Marc De Maeyer, Hans Deckmyn, Wim De Borggraeve
Pages: 11349 - 11351 - Biochemical characterization of highly purified leucine-rich repeat kinases 1 and 2 demonstrates formation of homodimers(2012)
Authors: Renée Vancraenenbroeck, Evy Lobbestael, Lauran Reyniers, Marc De Maeyer, Veerle Baekelandt, Jean-Marc Taymans
- Evidence for DBD-LBD communications in the androgen receptor(2012)
Authors: Christine Helsen, Vanessa Dubois, Annelien Verfaillie, Renée Vancraenenbroeck, Marc De Maeyer, Frank Claessens
Pages: 3033 - 3043 - Evidence for DNA-Binding Domain-Ligand-Binding Domain Communications in the Androgen Receptor(2012)
Authors: Christine Helsen, Vanessa Dubois, Annelien Verfaillie, Marc De Maeyer, Frank Claessens
Pages: 3033 - 3043
Patents
1 - 6 of 6
- Thieno[2,3-b]pyridine derivatives as viral replication inhibitors (Inventor)
- Thieno [2, 3-B] pyridine derivatives as viral replication inhibitors (Inventor)
- ;Antiviral compounds (Inventor)
- THIENO [2, 3-B] PYRIDINE DERIVATIVES AS VIRAL REPLICATION INHIBITORS (Inventor)
- NOVEL ANTIVIRAL COMPOUNDS (Inventor)
- VIRAL REPLICATION INHIBITORS (Inventor)